Notice2025-03539
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 5, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 42 (Wednesday, March 5, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 42 (Wednesday, March 5, 2025)]
[Notices]
[Page 11324]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-03539]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Vascular and Hematology Integrated Review
Group; Integrative Vascular Physiology and Pathology Study Section.
Date: March 24-25, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bukhtiar H Shah, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD
20892, (301) 806-7314, <a href="/cdn-cgi/l/email-protection#c9baa1a8a1ab89aababbe7a7a0a1e7aea6bf"><span class="__cf_email__" data-cfemail="64170c050c06240717164a0a0d0c4a030b12">[email protected]</span></a>.
Name of Committee: Applied Therapeutics for Cancer Integrated
Review Group; Mechanisms of Cancer Therapeutics A Study Section.
Date: March 31-April 1, 2025.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Careen K Tang-Toth, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD
20892, (301) 435-3504, <a href="/cdn-cgi/l/email-protection#f3879c879b9087b3908081dd9d9a9bdd949c85"><span class="__cf_email__" data-cfemail="e5918a918d8691a5869697cb8b8c8dcb828a93">[email protected]</span></a>.
Name of Committee: Applied Therapeutics for Cancer Integrated
Review Group; Mechanisms of Cancer Therapeutics C Study Section.
Date: April 1-2, 2025.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Gloria Huei-Ting Su, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-496-0465,
<a href="/cdn-cgi/l/email-protection#ea8d868598838bc4999faa848382c48d859c"><span class="__cf_email__" data-cfemail="c4a3a8abb6ada5eab7b184aaadaceaa3abb2">[email protected]</span></a>.
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Biomaterials and Biointerfaces Study
Section.
Date: April 2-3, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jennifer Fiori O'Connell, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (410) 454-8478,
<a href="/cdn-cgi/l/email-protection#d8b2bdb6b6b1bebdaaf6b7bbb7b6b6bdb4b498b6b1b0f6bfb7ae"><span class="__cf_email__" data-cfemail="aec4cbc0c0c7c8cbdc80c1cdc1c0c0cbc2c2eec0c7c680c9c1d8">[email protected]</span></a>.
Name of Committee: Oncology 1-Basic Translational Integrated
Review Group; Gene Regulation in Cancer Study Section.
Date: April 21-22, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Manzoor A. Zarger, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208, MSC 7804, Bethesda, MD
20892, (301) 435-2477, <a href="/cdn-cgi/l/email-protection#95eff4e7f2f0e7f8f4d5f6e6e7bbfbfcfdbbf2fae3"><span class="__cf_email__" data-cfemail="e993889b8e8c9b8488a98a9a9bc7878081c78e869f">[email protected]</span></a>.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Interventions to Prevent and Treat
Addictions Study Section.
Date: April 23-25, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Izabella Zandberg, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301-594-0359, <a href="/cdn-cgi/l/email-protection#583122393a3d343439762239363c3a3d2a3f18363130763f372e"><span class="__cf_email__" data-cfemail="88e1f2e9eaede4e4e9a6f2e9e6eceaedfaefc8e6e1e0a6efe7fe">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 28, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-03539 Filed 3-4-25; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 5, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.